Drug intelligence / Profile preview

Huang-Qi-Ling-Hua-San

Development stage
Preclinical
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Huang-Qi-Ling-Hua-San (HQLHS) is a traditional Chinese medicine formula specifically designed for the management of type 2 diabetes. It is composed primarily of Astragalus membranaceus (Huang Qi), Ganoderma lucidum (Ling Zhi), Inonotus obliquus, and Momordica charantia L., with some commercial variants including additional herbs such as Ophiopogon root, Schisandra fruit, Ligustrum fruit, Siberian Ginseng root, White Atractylodes rhizome, Dendrobium herb, Lycium fruit (Goji berry), Polygonum root (He Shou Wu), Dong Quai root (Dang Gui), Codonopsis root (Dang Shen), White Chinese Ginseng root (Bai Ji Lin Shen), Eucommia bark (Du Zhong), Citrus peel and Chinese Licorice root. The formula acts by modulating gut microbiota—particularly enriching beneficial bacteria such as Bifidobacterium and Christensenella—which in turn improves glucose and lipid metabolism. Mechanistically it promotes GLP-1 secretion, increases antioxidant capacity, inhibits hepatic gluconeogenesis and intestinal glucose absorption while enhancing the intestinal barrier function and reducing inflammation. Traditionally it is also used to boost qi (“vital energy”), enrich yin (“nourishing fluids”), nourish blood and strengthen spleen/kidney function[1][4][6][7][8].

Brand names
Huang Qi Ling Hua SanHuang Qi Ling Zhi SanAstragalus & Ganoderma
Other names
HQLHS黄芪灵华散
02

Targets

SLC5A1 (Sodium Glucose Cotransporter 1)GLP1R (GLP-1R)G6PC1 (Glucose 6-phosphatase alpha)

Beyond the preview

Go deeper on Huang-Qi-Ling-Hua-San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huang-Qi-Ling-Hua-San.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call